Subir Bhatia

Subir Bhatia practices at Centinela Hospital Medical Center in Inglewood, California, part of Prime Healthcare Services.

Subir Bhatia's NPI, 1164885158, was assigned on March 29, 2016. Subir Bhatia graduated from UC Irvine School of Medicine in 2015. Subir Bhatia holds California license A161812.

Subir Bhatia's primary practice is Centinela Hospital Medical Center, at 555 East Hardy Street, Inglewood, CA 90301 in Los Angeles County. The practice phone is (310) 673-4660.

Subir Bhatia's primary practice is Centinela Hospital Medical Center in Inglewood, California, part of Prime Healthcare Services. Subir Bhatia is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Epic Medical Group. Dmand AI also links Subir Bhatia to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Subir Bhatia practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Subir Bhatia's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Subir Bhatia is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Subir Bhatia's licenses on file in 4 states: California, North Carolina, Minnesota and Texas.

Dmand AI lists atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease, heart failure, heart valve disorders and intermittent racing heartbeat (PSVT) among the conditions Subir Bhatia treats.

CMS data shows 3,466 Medicare services from Subir Bhatia across 13 procedure codes in 2024, for 758 Medicare patients. Medicare paid $328,478 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 758 Medicare patients who saw Subir Bhatia in 2024. The largest group is 65 to 74, with 331 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 85% are also on Medicaid. Their average risk score is 3.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Subir Bhatia's median patient age at 64, with 49% women.

In 2024, Subir Bhatia wrote 156 Medicare Part D claims for 61 patients. 74% of them were for generic drugs. CMS names the drug for 68 of them, across 5 drugs with 11 or more claims each, at $31,711 in total drug cost. In 2023, CMS named 896 claims across 20 drugs.

Subir Bhatia accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 25 papers to Subir Bhatia, published from 2015 to 2025. 2017 was the busiest year, with 7. The most frequent topics are Electrocardiography, Atrial Fibrillation and Cardiomyopathies. Subir Bhatia has published most often in Mayo Clin Proc. Subir Bhatia's most frequent co-authors are Nandan S. Anavekar, MBCHB, Sravya Mallam Bhatia, MD and Samuel J. Asirvatham, MD.

CMS Open Payments shows 118 general payments to Subir Bhatia from 24 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 92% of the total. Abbott Laboratories paid the most, $1,022.

Subir Bhatia graduated from UC Irvine School of Medicine in 2015.

Subir Bhatia is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.